There are less than two months to go until IAS 2023, the 12th IAS Conference on HIV Science, kicks off! Take a look at some of the HIV treatment research highlights you can expect at the world’s most influential meeting on HIV research.

Register for IAS 2023 today and join thousands of HIV professionals in Brisbane, Australia, and virtually.

IAS 2023 will take place from 23 to 26 July 2023.

If you are planning to attend IAS 2023 in person, we strongly recommend that you apply for a visa as soon as possible. Learn more here.

Some HIV treatment research highlights to expect at IAS 2023

IAS 2023 will feature the latest science on long-acting therapy, biodegradable implants, treatment data among people who inject drugs, and much more! HIV treatment and co-morbidities scientific highlights will include:

  • Results of an open-label study evaluating the pharmacokinetics, safety and efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed pregnant women living with HIV
  • Findings from an effort to transform three short-acting HIV drugs – tenofovir, lamivudine and dolutegravir (TLD) – into a novel, long-acting triple therapy in a single injectable dosage
  • Insights on a biodegradable, subcutaneous implant delivery platform that could treat HIV for up to six months in young children
  • New evidence that post-treatment controllers exhibit distinct CD8+ T cell features >before and after ART interruption
  • A global systematic review and meta-analysis quantifying HIV treatment outcomes among people who inject drugs

About IAS 2023

The IAS Conference on HIV Science is the world’s most influential meeting on HIV research and its applications. This biennial conference presents the critical advances in basic, clinical and operational HIV research that move science into policy and practice.

IAS 2023, being held at the Brisbane Convention & Exhibition Centre, will shine a spotlight on the world’s advances in HIV research.